Finance·Jul 20, 2026
Samsung Biologics Offers $1.8 Billion for Swiss Peptide Manufacturer
The South Korean biotech giant aims to expand into obesity and diabetes drug production through the all-cash acquisition of PolyPeptide
By Cheng Wei-Lun · 3 min ·

